Keywords
Human gamma globulin
Hematopoietic progenitor cell transplant
Abstract
Background: Patients with common variable immunodeficiency show higher incidence of sinopulmonary and gastrointestinal infections, as well as lymphoproliferative and autoimmune diseases. The treatment of choice is replacement therapy with human gamma-globulin. Hematopoietic stem cell transplantation is a non-conventional therapeutic modality.
Clinical case: Twenty-six-year old woman with no family or hereditary history of primary immune deficiencies or consanguinity, with repeated episodes of otitis, sinusitis, gastroenteritis and bronchitis since childhood. At adolescence, she was diagnosed with common variable immunodeficiency; she was prescribed intravenous gamma-globulin, broad-spectrum antimicrobials and macrolides. At 22 years of age, she underwent hematopoietic stem cell transplantation owing to continued severe infections. At 4 months, post-transplantation she was diagnosed with hypothyroidism and ovarian insufficiency. During the following 3 years, she had no infections, but at 25 years of age she had immune thrombocytopenic purpura diagnosed, which persists together with Raynaud’s disease and upper respiratory tract persistent infections. At the moment of this report she is being treated with intravenous gamma-globulin and receiving prophylaxis with clarithromycin, without steroids or danazol.
Conclusions: Given the high rate of morbidity and mortality associated and immune reconstitution failure, hematopoietic stem cell transplantation should be carefully evaluated in patients with treatment-unresponsive infections or lymphoproliferative disorders.
References
Aydogan M, Eifan AO, Gocmen I, Ozdemir C, Bahceciler NN, Barlan IB. Clinical and Immunologic features of pediatric patients with common variable immunodeficiency and respiratory complications. J Investig Allergol Clin Immunol. 2008,18(4):260-265. Disponible en: http://www.jiaci.org/summary/vol18-issue4-num355
Thickett KM, Kumararatne DS, Banerjee AK, Dudley R, Stableforth DE. Common variable immunodeficiency: Respiratory manifestations, pulmonary function and high-resolution CT scan findings. Q J Med. 2002;95:655-662.
Gómez-Morales E. Trasplante de médula ósea. Experiencia en México. Gac Med Mex. 2002;138(Supl 1):135-144. Disponible en: http://www.medigraphic.com/pdfs/gaceta/gm-2002/gms021u.pdf
Ardeniz O, Başoğlu OK, Günşar F, Unsel M, Bayraktaroğlu S, Mete N, et al. Clinical and immunological analysis of 23 adult patients with common variable immunodeficiency. J Investig Allergol Clin Immunol, 2010;20(3):222-236. Disponible en: http://www.jiaci.org/summary/vol20-issue3-num589
Vodjgani M, Aghamohammadi A, Samadi M, Moin M, Hadjati J, Mirahmadian M, et al. Analysis of class-switched memory B cells in patients with common variable immunodeficiency and its clinical implications. J Investig Allergol Clin Immunol. 2007;17(5):321-328. Dispionible en: http://www.jiaci.org/summary/vol17-issue5-num258
Bright P, Grigoriadou S, Kamperidis P, Buckland M, Hickey A, Longhurst HJ. Changes in B cell immunophenotype in common variable immunodeficiency: Cause or effect? Clin Exper Immunol. 2012;171(2):195-200. DOI: http://dx.doi.org/10.1111/cei.12010.
Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immunodeficiency over 4 decades. Am Soc Hematol. 2011;119(7):1650-1657. DOI: http://dx.doi.org/10.1182/blood-2011-09-377945
Busse PJ, Farzan S, Cunningham-Rundles C. Pulmonary complications of common variable immunodeficiency. Ann Allergy Asthma Immunol. 2007;98:1-8. DOI: http://dx.doi.org/10.1016/S1081-1206(10)60853-8
Spickett G. Current perspectives on common variable immunodeficiency. Clin Exp Allergy. 2001;31(4):536-542.
Abolhassani H, Sagvand BT, Shokuhfar T, Mirminachi B, Rezaei N, Aghamohammadi A. A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol. 2013;9(6):561-574. DOI: http://dx.doi.org/10.1586/eci.13.30
Chapel H, Lucas M, Lee M, Bjorkander J, Webster D, Grimbacher B. Common variable immunodeficiency disorders: Division into distinct clinical phenotypes. Blood. 2008;112(2):277-286. DOI: http://dx.doi.org/10.1182/blood-2007-11-124545
Wehr C, Gennery AR, Lindemans C, Schulz A, Hoenig M, Marks R. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol. 2015;135(4): 988.e6-997.e6. DOI: http://dx.doi.org/10.1016/j.jaci.2014.11.029
Rizzi M, Neumann C, Fielding AK, Marks R, Goldacker S, Thaventhiran J, et al. Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency. J Allergy Clin Immunol. 2011;128(6):1371.e2-1374.e2. DOI: http://dx.doi.org/10.1016/j.jaci.2011.07.055
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2017 Revista Alergia México